Coherus Oncology, Inc. (CHRS) research
Coherus Oncology, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.35
- As of
Coherus Oncology, Inc. (CHRS): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-28.
As of . Source: SEC EDGAR filings for CHRS. Method and limitations.
Share the CHRS intelligence card
See CHRS live in the terminal
Track CHRS's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live CHRS terminal, freeActive signals for CHRS
- highCONSENSUS_SELL
3 tracked funds reduced CHRS this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 93% of CHRS (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +70% to CHRS (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +451% to CHRS (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +101% to CHRS (2026Q2)
FREE, NO ACCOUNT
Every signal on CHRS, as it fires
You are seeing 5 of 21 signals recorded on CHRS since 2026-05-16.
The five above landed across 2 days. The other 16 were recorded on 4 other days. 17 of the 21 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CHRS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LPCUSIP 19249H103 · 2026Q2 | $3.2M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 19249H103 · 2026Q2 | $788K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 19249H103 · 2026Q2 | $59K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 19249H103 · 2026Q2 | $29K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CHRS
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
See more CHRS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CHRSand get the insider, 13F, options, and confluence read in one view.